摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2,5,6-tetrahydro-8-(hydroxy(pyridin-4-yl)methyl)pyrrolo[3,2,1-ij]quinolin-4-one | 1194451-08-5

中文名称
——
中文别名
——
英文名称
1,2,5,6-tetrahydro-8-(hydroxy(pyridin-4-yl)methyl)pyrrolo[3,2,1-ij]quinolin-4-one
英文别名
6-[Hydroxy(pyridin-4-yl)methyl]-1-azatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-trien-11-one
1,2,5,6-tetrahydro-8-(hydroxy(pyridin-4-yl)methyl)pyrrolo[3,2,1-ij]quinolin-4-one化学式
CAS
1194451-08-5
化学式
C17H16N2O2
mdl
——
分子量
280.326
InChiKey
LMKFQLJABRFIRD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    21
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    53.4
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,2,5,6-tetrahydro-8-(hydroxy(pyridin-4-yl)methyl)pyrrolo[3,2,1-ij]quinolin-4-one三乙基硅烷三氟甲磺酸三氟乙酸碳酸氢钠 作用下, 以 二氯甲烷 为溶剂, 反应 48.0h, 以55%的产率得到1,2,5,6-tetrahydro-8-((pyridin-4-yl)methyl)pyrrolo[3,2,1-ij]quinolin-4-one
    参考文献:
    名称:
    Inhibitors of the Human Aldosterone Sythase CYP11B2
    摘要:
    该发明提供了一般式(I)的化合物,这些化合物是人类醛固酮合成酶的抑制剂,还包括含有这些化合物的药物组合物,以及使用这些化合物治疗高醛固酮症和/或由11β-羟化酶(CYP11B1)介导的疾病或疾病的方法。
    公开号:
    US20110112067A1
  • 作为产物:
    描述:
    氯化异氰盐酸盐甲醇 、 aluminum (III) chloride 、 sodium tetrahydroborate 作用下, 反应 5.0h, 生成 1,2,5,6-tetrahydro-8-(hydroxy(pyridin-4-yl)methyl)pyrrolo[3,2,1-ij]quinolin-4-one
    参考文献:
    名称:
    Tetrahydropyrroloquinolinone Type Dual Inhibitors of Aromatase/Aldosterone Synthase as a Novel Strategy for Breast Cancer Patients with Elevated Cardiovascular Risks
    摘要:
    The application of aromatase inhibitors to postmenopausal breast cancer patients increases the risk of cardiovascular diseases (CVD), which is believed to be caused by the abnormally high concentrations of aldosterone as a consequence of the estrogen deficiency. Dual inhibitors of aromatase (CYP19) and aldosterone synthase (CYP11B2) are therefore proposed as a novel strategy for the adjuvant therapy to reduce the CVD risk for these patients. By combining decisive structural features of CYP11B2 and CYP19 inhibitors into a common template, a series of pyridinylmethyl substituted 1,2,5,6-tetrahydro-pyrrolo [3,2,1-ij]quinolin-4-ones were designed and synthesized. Interestingly, the substituents on the methylene bridge showed strong influences on the inhibitory activities leading to opposite effects, that is, a given substituent showed an increase in inhibition of one enzyme, while it led to a decrease for the other enzyme. The compromise of this conflict led to compounds 3j, 3k, 3n, and 3p as potent and selective dual inhibitors of CYP19 and CYP11B2, especially compound 3p, which exhibited IC50 values of 32 and 41 nM for CYP19 and CYP11B2, respectively, and a high selectivity toward CYP17 and CYP11B1. This compound is considered as a candidate for further evaluation in vivo.
    DOI:
    10.1021/jm301408t
点击查看最新优质反应信息

文献信息

  • Inhibitors of the Human Aldosterone Sythase CYP11B2
    申请人:Hartmann Rolf W.
    公开号:US20110112067A1
    公开(公告)日:2011-05-12
    The invention provides compounds of the general formula (I) which are inhibitors of the human aldosterone synthase, and also pharmaceutical compositions containing these compounds, and a method of treating of hyperaldosteronism and/or disorders or diseases that are mediated by 11β-hydroxylase (CYP11B1) with these compounds.
    该发明提供了一般式(I)的化合物,这些化合物是人类醛固酮合成酶的抑制剂,还包括含有这些化合物的药物组合物,以及使用这些化合物治疗高醛固酮症和/或由11β-羟化酶(CYP11B1)介导的疾病或疾病的方法。
  • 6-Pyridin-3-YL-3,4-Dihydro-1H-Quinolin-2-One Derivatives and Related Compounds as Inhibitors of the Human Aldosterone Synthase CYP11B2
    申请人:Hartmann Rolf W.
    公开号:US20110118241A1
    公开(公告)日:2011-05-19
    The invention provides compounds of the general formula (I) which are inhibitors of the human aldosterone synthase, and also pharmaceutical compositions containing these compounds, and the use of these compounds and other heteroaryl substituted quinolinone derivatives for the treatment of hyperaldosteronism and/or disorders or diseases that are mediated by 11 β-hydroxylase (CYP11 B1).
    本发明提供了一般式(I)的化合物,它们是人类醛固酮合成酶的抑制剂,还提供了含有这些化合物的制药组合物以及使用这些化合物和其他杂环取代喹啉酮衍生物治疗高醛固酮症和/或11β-羟化酶(CYP11B1)介导的疾病或疾病的方法。
  • [EN] 6-PYRIDIN-3-YL-3,4-DIHYDRO-1H-QUINOLIN-2-ONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE HUMAN ALDOSTERONE SYNTHASE CYP11B2<br/>[FR] DÉRIVÉS DE 6-PYRIDIN-3-YL-3,4-DIHYDRO-1H-QUINOLIN-2-ONE ET COMPOSÉS APPARENTÉS EN TANT QU'INHIBITEURS DE L'ALDOSTÉRONE SYNTHASE CYP11B2 HUMAINE
    申请人:UNIV SAARLAND
    公开号:WO2009135651A8
    公开(公告)日:2010-01-21
  • 6-PYRIDIN-3-YL-3,4-DIHYDRO-1H-QUINOLIN-2-ONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE HUMAN ALDOSTERONE SYNTHASE CYP11B2
    申请人:Universität des Saarlandes
    公开号:EP2280954B1
    公开(公告)日:2013-03-27
  • US8541404B2
    申请人:——
    公开号:US8541404B2
    公开(公告)日:2013-09-24
查看更多